On January 4, 2019, the US Patent and Trademark Office (USPTO) announced revised guidance for determining subject matter eligibility under 35 U.S.C. § 101 for computer-implemented inventions (Guidance). The Guidance takes effect Monday, January 7, 2019. The Guidance is important for medical patents that use algorithms for diagnosis and treatment decisions in personalized medicine.
Two Primary Changes to Improve Clarity
Two primary changes on how patent examiners should apply the first part of the two part U.S. Supreme Court’s Alice/Mayo test, are made to improve “clarity, consistency, and predictability of actions across the USPTO” (quoting Under Secretary of Commerce of Intellectual Property and Director of the USPTO Andrei Iancu Guidance Press Release):
Guidance Press Release
Public Comments Requested
The USPTO is seeking public comment on the Guidance documents. The public is invited to submit comments and suggestions for future guidance documents to Eligibility2019@USPTO.gov on or before March 8, 2019.